BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28938421)

  • 1. Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
    Bullova P; Cougnoux A; Marzouca G; Kopacek J; Pacak K
    Endocrinology; 2017 Oct; 158(10):3097-3108. PubMed ID: 28938421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
    Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models.
    Bullova P; Cougnoux A; Abunimer L; Kopacek J; Pastorekova S; Pacak K
    Oncotarget; 2016 Jun; 7(26):40531-40545. PubMed ID: 27244895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
    Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
    Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
    Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
    PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
    Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO
    Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo.
    Manton CA; Johnson B; Singh M; Bailey CP; Bouchier-Hayes L; Chandra J
    Sci Rep; 2016 Jan; 6():18953. PubMed ID: 26804704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors.
    Chao A; Wang TH
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):3-8. PubMed ID: 26927239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
    Chauhan D; Catley L; Li G; Podar K; Hideshima T; Velankar M; Mitsiades C; Mitsiades N; Yasui H; Letai A; Ovaa H; Berkers C; Nicholson B; Chao TH; Neuteboom ST; Richardson P; Palladino MA; Anderson KC
    Cancer Cell; 2005 Nov; 8(5):407-19. PubMed ID: 16286248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.
    Mehdizadeh K; Ataei F; Hosseinkhani S
    Med Oncol; 2021 Apr; 38(6):64. PubMed ID: 33904968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
    Park J; Park E; Jung CK; Kang SW; Kim BG; Jung Y; Kim TH; Lim JY; Lee SE; Min CK; Won KA
    BMC Cancer; 2016 Mar; 16():247. PubMed ID: 27012957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.
    Yang L; Zhang S; George SK; Teng R; You X; Xu M; Liu H; Sun X; Amin HM; Shi W
    Oncotarget; 2015 Jun; 6(17):14953-69. PubMed ID: 25879451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
    Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
    Endokrynol Pol; 2013; 64(5):368-74. PubMed ID: 24186594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.
    Martiniova L; Lu J; Chiang J; Bernardo M; Lonser R; Zhuang Z; Pacak K
    PLoS One; 2011 Feb; 6(2):e14678. PubMed ID: 21339823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
    Xian M; Cao H; Cao J; Shao X; Zhu D; Zhang N; Huang P; Li W; Yang B; Ying M; He Q
    Int J Cancer; 2017 Sep; 141(5):1029-1041. PubMed ID: 28524233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition for the treatment of glioblastoma.
    Roth P; Mason WP; Richardson PG; Weller M
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1133-1141. PubMed ID: 32746640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
    Brignole C; Marimpietri D; Pastorino F; Nico B; Di Paolo D; Cioni M; Piccardi F; Cilli M; Pezzolo A; Corrias MV; Pistoia V; Ribatti D; Pagnan G; Ponzoni M
    J Natl Cancer Inst; 2006 Aug; 98(16):1142-57. PubMed ID: 16912267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.
    Pacak K; Sirova M; Giubellino A; Lencesova L; Csaderova L; Laukova M; Hudecova S; Krizanova O
    Int J Cancer; 2012 Nov; 131(10):2445-55. PubMed ID: 22407736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
    Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
    Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.